COVID-19 Vaccination Acceptance and Its Associated Factors among Cancer Patients in Tunisia.
Asian Pac J Cancer Prev
; 22(11): 3499-3506, 2021 Nov 01.
Article
in English
| MEDLINE | ID: covidwho-1539062
ABSTRACT
BACKGROUND:
Vaccination is the most effective way to fight the COVID-19 pandemic and to protect people who have a higher risk of developing severe illness and death from COVID-19 such as cancer patients. We aimed in this study to determine the acceptance rate of COVID-19 vaccination of the Salah Azaiez Institute (SAI) of cancer of Tunisia patients and to identify its associated factors.METHODS:
It was a cross sectional study about patients admitted to the SAI for treatment during the month of February 2021. Univariate and multivariate analyses were performed to identify factors associated with the COVID-19 vaccine acceptance among Tunisian cancer patients.RESULTS:
A total of 200 patients were included in this study with a mean age of 54.4±12.7 years and a gender ratio of 0.5. Only 35.0% of surveyed patients reported their acceptance to receive the COVID-19 vaccine. Multivariate analysis showed that believing in COVID-19 vaccine safety and efficacy (OR=3.1 [1.3-7.4]), enrollment in the COVID-19 vaccine platform (OR=8.3 [1.8-38.1]) and the willingness to receive influenza vaccine (OR=3.9 [1.6-9.3]) were independently associated with the COVID-19 vaccine acceptance among SAI cancer patients.CONCLUSIONS:
The COVID-19 vaccine acceptance rate found in this study was low. Communication strategies of the vaccination campaigns should provide clear, simple and detailed messages about the efficacy and the benefits of the COVID-19 vaccines. More engagement of health authorities to promote COVID-19 vaccination is necessary.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Patient Acceptance of Health Care
/
Health Knowledge, Attitudes, Practice
/
Vaccination
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
/
Neoplasms
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Vaccines
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
/
Young adult
Country/Region as subject:
Africa
Language:
English
Journal:
Asian Pac J Cancer Prev
Journal subject:
Neoplasms
Year:
2021
Document Type:
Article
Affiliation country:
Apjcp.2021.22.11.3499
Similar
MEDLINE
...
LILACS
LIS